Skip to main content
NCBI home page
Journal of Cancer Research and Clinical Oncology logoLink to Journal of Cancer Research and Clinical Oncology
. 1994 Jun;120(6):331–347. doi: 10.1007/BF01247458

Mesothelioma-like tumors of the pleura: a review of 72 autopsy cases

C -A Hartmann 1,✉, H Schütze 3
PMCID: PMC12201207  PMID: 8138558

Abstract

The 72 mesothelioma-like tumors of the pleura (MLTP) found among 33 500 autopsy cases collected over more than 30 years are reviewed. MLTP have a worse prognosis than the 106 cases of pleural mesothelioma autopsied in our institutes with regard to survival time and metastatic spread. In MLTP, adenocarcinomas predominate with a wide range of histological and cytological variation and prominent development of connective tissue having its origin in the periphery of the lung. These intrapulmonary primary tumors often fulfill the criteria of pulmonary scar cancer. Etiologically, there is no correlation between the origin of this tumor and smoking or exposure to asbestos. The absence of mucus formation and glandular differentiation, together with the presence of spindle-shaped carcinoma components and strong mesothelial or stroma proliferation, can make the differential diagnosis between this tumor type and mesothelioma difficult. Immunohistological investigations were performed on 11 cases with antibodies against intermediate filament proteins, vascular endothelium, collagen IV, macrophage antigens, carcinoembryonic antigen (CEA), LeuM1, and the antibody BerEP4. Our investigation shows that a battery of several tumor markers, such as antibodies against LeuM1, CEA, and the antibody BerEP4, as well as staining with periodic acid/Schiff/diastase discriminate primary from secondary pleural neoplasms, whilst intermediate filament proteins alone are of little diagnostic value.

Key words: Mesothelioma-like carcinosis, Pseudo-mesotheliomatous tumor of the pleura, Differential diagnosis, Metastases, Etiology

References

  1. Adams VI, Unni KK (1984) Diffuse malignant mesothelioma of pleura: diagnostic criteria bases on an autopsy study. Am J Clin Pathol 82:15–23 [DOI] [PubMed] [Google Scholar]
  2. Battifora H, Kopinski MI (1985) Distinction of mesothelioma from adenocarcinoma. An immunohistochemical approach. Cancer 55:1679–1685 [DOI] [PubMed] [Google Scholar]
  3. Bolen JW, Hammar SP, McNutt MA (1986) Reactive and neoplastic serosal tissue. A light-microscopic, ultrastructural, and immunocytochemical study. Am J Surg Pathol 10:34–47 [DOI] [PubMed] [Google Scholar]
  4. Braganza JM, Butler B, Fox H, Hunter PM, Quereshi MSA, Samargi W, Vatton AG (1978) Ectopic production of salivary type amylase by a pseudomesotheliomatous carcinoma of the lung. Cancer 41:1522–1525 [DOI] [PubMed] [Google Scholar]
  5. Brenner J, Sordillo PP, Magill GB, Goldberg RB (1982) Malignant mesothelioma of the pleura. Review of 123 patients. Cancer 49:2431–2435 [DOI] [PubMed] [Google Scholar]
  6. Brockmann M (1992) Malignes diffuses Pleuramesotheliom-Heterogenität, Differentialdiagnose und Histogenese. In: HVBG, ed Forschungsbericht Pleuramesotheliom
  7. Broghammer WL, Collins WM, Mojsejinho IK (1978) The cytohistopathology of a pseudomesotheliomatous carcinoma of the lung. Acta Cytol 22:239–242 [PubMed] [Google Scholar]
  8. Carrington Ch (1982) Mesothelioma panels. Arch Pathol Lab Med 106:592 [Google Scholar]
  9. Churg A (1985) Immunohistochemical staining for vimentin and keratin in malignant mesothelioma. Am J Surg Pathol 9:360–365 [DOI] [PubMed] [Google Scholar]
  10. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, Macdonald ST, Pulford KAF, Stein H, Mason DY (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatases and monoclonal anti-alkaline phosphatases (APAAP complexes) J Histochem Cytochem 32:219–229 [DOI] [PubMed] [Google Scholar]
  11. Craighead JE, Abraham JL, Churg A, Green FHY, Kleinermann J, Pratt PhC, Seemayer ThA, Vallyathan V, Weill H (1982) The pathology of asbestos-associated diseases of the lungs and pleural cavities: diagnostic criteria and proposed grading schema. Arch Pathol Lab Med 106:544–597 [PubMed] [Google Scholar]
  12. Dessy E, Pietra GG (1991) Pseudomesotheliomatous carcinoma of the lung. An immunohistochemical and ultrastructural study of three cases. Cancer 68:1747–1753 [DOI] [PubMed] [Google Scholar]
  13. Edwards CW (1987) Pulmonary adenocarcinoma: review of 106 cases and proposed new classification. J Clin Pathol 40:125–135 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. El-Naggar AD, Ordonez NG, Garnsey L, Batsakis JG (1991) Epitheloid pleural mesotheliomas and pulmonary adenocarcinomas: a comparative DNA flow cytometric study. Hum Pathol 22:972–978 [DOI] [PubMed] [Google Scholar]
  15. Fukuyama M, Maeda Y, Funata N, Kaike M, Saito K S Dakai T, Ikeda T (1988) Pulmonary and pleural thymoma. Diagnostic application of lymphocyte markers to the thymoma of unusual site. Am J Clin Pathol 89:617–622 [DOI] [PubMed] [Google Scholar]
  16. Gatter KC, Dunnill MS, v Muijen GNP, Mason DY (1986) Human lung tumours may coexpress different classes of intermediate filaments. J Clin Pathol 39:950–954 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ghosh AK, Gatter KC, Dunnill MS, Mason DY (1987) Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies. J Clin Pathol 40:19–25 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Greenberg M, Lloyd-Davis TA (1974) Mesothelioma registry: 1967–1968. Br J Ind Med 32:91–104 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hackl H, Wolf D (1977) Pleurakarzinose bei kleinem Hypernephrom als differentialdiagnostisches Problem zum diffusen Pleuramesotheliom. Prax Pneumol 31:208–213 [PubMed] [Google Scholar]
  20. Hartmann C-A (1984) Das Pleuramesotheliom im Sektionsgut des Instituts für Pathologie des Krankenhauses Spandau. Prax Pneumol 39:59–64 [PubMed] [Google Scholar]
  21. Hartmann C-A, Hanke S (1984) Ungewöhnliche Pleurabeteiligung eines Thymoms. Pathologe 5:169–172 [PubMed] [Google Scholar]
  22. Hartmann C-A, Minck C (1988) Metastasierendes Cystosarcom phylloides mit pseudomesotheliomatöser Sarkomatose der kontralateralen Pleurablätter Pathologe 9:119–123 [PubMed] [Google Scholar]
  23. Hartmann C-A, Schütze H (1992) Metastasierungsfrequenz und Überlebenszeit histologischer Subtypen des Pleuramesothelioms. Autopsiestudie an 106 Fällen. Pathologe 13:259–268 [PubMed] [Google Scholar]
  24. Harwood TR, Gracey DR, Yokoo H (1976) Pseudomesotheliomatous earcinoma of the lung. A variant of peripheral lung cancer. Am J Clin Pathol 65:159–167 [DOI] [PubMed] [Google Scholar]
  25. Hillerdal G, Berg J (1985) Malignant mesothelioma secundary to chronic inflammation and old scars. Two new cases and review of the literature. Cancer 55:1968–1972 [DOI] [PubMed] [Google Scholar]
  26. Hofmann W, Möller P, Manke H-G, Otto H-F (1985) Thymoma. A clinicopathologic study of 98 cases with special reference to three unusual cases. Pathol Res Pract 179:337–356 [PubMed] [Google Scholar]
  27. Höpker W-W, Lüllig H (1986) Lungenkarzinom. Resektion, Morphologie und Prognose. Springer, Berlin Heidelberg New York, pp 21–50, 85–141, 153–181 [Google Scholar]
  28. Huang WM, Gibson SJ, Facer P, Gu J, Polak JM (1983) Improved section adhesion for immunocytochemistry using high molecular weight polymers ofl-lysine as a slide coating, Histochemistry 77:275–279 [DOI] [PubMed] [Google Scholar]
  29. Kannerstein M, Churg J (1977) Peritoneal mesothelioma. Hum Pathol 8:83–94 [DOI] [PubMed] [Google Scholar]
  30. Kannerstein M, Churg J, McCaughey WTE (1980) Functions of mesothelioma panels. Ann NY Acad Sci 330:433–439 [DOI] [PubMed] [Google Scholar]
  31. Klemperer P, Rabin CB (1931) Primary neoplasm of the pleura. A report of five cases. Arch Pathol 11:385–412 [Google Scholar]
  32. Kung ITM, Mok ChK, Lui IOL, Lam WK, Loke ShL, So ShY, Khin MA (1985) Pulmonary scar cancer. A pathologic reappraisal. Am J Surg Pathol 9:391–400 [DOI] [PubMed] [Google Scholar]
  33. Kwee WS, Veldhuizen RW, Golding RP, Donner R (1981) Primary “adenosquamous” mesothelioma of the pleura. Virchows Arch [A] 393:353–357 [Google Scholar]
  34. Latour A, Shulman HS (1976) Thoracic manifestations of renal cell carcinomas. Radiology 121:43–48 [DOI] [PubMed] [Google Scholar]
  35. Latza U, Stein H, Schwarting R, Niedobitek G (1990) EP 4: a new monoclonal antibody against human epithelial glycoprotein that discriminate epithelia from mesothelia. J Clin Pathol 43:213–219 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Lin J, Tsung CH, Tsung SH (1980) Pseudomesotheliomatous carcinoma of the lung. South Med J 73:655–657 [DOI] [PubMed] [Google Scholar]
  37. McCaughey WTE (1965) Criteria for the diagnosis of diffuse mesothelial tumors. Ann NY Acad Sci 132:603–613 [DOI] [PubMed] [Google Scholar]
  38. McDonald AD, Magner D, Eyssen G (1973) Primary malignant mesothelioma in Canada. 1960–1968. A pathologic review by the mesothelioma panel of the Canadian Tumor reference Centre. Cancer 31:869–876 [DOI] [PubMed] [Google Scholar]
  39. Müller K-M (1983a) Lungentumoren. In: Doerr W, Seifert G (eds) Pathologie der Lunge II. (Spez path Anat 16/II) Springer, Berlin Heidelberg New York, pp 1081–1187 [Google Scholar]
  40. Müller K-M (1983b) Pleura. In: Doerr W, Seifert G (eds) Pathologie der Lunge II. (Spez path Anat 16/II) Springer, Berlin Heidelberg New York, pp 1366–1398 [Google Scholar]
  41. Nishimoto Y, Ohno T, Saito K (1983) Pseudomesotheliomatous carcinoma of the lung with histochemical and immunohistochemical study. Acta Pathol Jpr 33:415–423 [DOI] [PubMed] [Google Scholar]
  42. O'Hara CJ, Corson JM, Pinkus GS, Stahel RA (1990) ME1 a monoclonal antibody that distinguishes epithelial-type malignant mesothelioma from pulmonary adenocarcinoma and extrapulmonary malignancies. Am J Pathol 136:421–428 [PMC free article] [PubMed] [Google Scholar]
  43. Ordonez NG (1989) The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma. Am J Surg Pathol 13:276–291 [PubMed] [Google Scholar]
  44. Otto H (1985) Pathology of pleural mesothelioma. Thorax Cadiovasc Surg 33:332–334 [DOI] [PubMed] [Google Scholar]
  45. Robertson HE (1924) “Endothelioma” of the pleura. Am J Cancer Res 8:317–375 [Google Scholar]
  46. Rüttner JR, Heinzl S (1977) Squamous-cell carcinoma of the pleura. Thorax 32:497–500 [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Sheibani K, Battifora H, Burke JS (1986) Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of LeuM1 antigen. Am J Pathol 123:212–219 [PMC free article] [PubMed] [Google Scholar]
  48. Simonsen J (1986) Pseudomesotheliomatous carcinoma of the lung with asbestos exposure. Am J Forensic Clin Pathol 7:49–51 [DOI] [PubMed] [Google Scholar]
  49. Sommer Th, Kantartzis M, Garcia M, Schubert GE (1981) Pleurametastasen können ein Mesotheliom vortäuschen. Med Klin 76:626–629 [PubMed] [Google Scholar]
  50. Spencer H (1985) Pathology of the lung, vol 2 4th edn Pergamon Press, Oxford, pp 837–932, 1006–1010 [Google Scholar]
  51. Stein H, Gatter K, Asbahr H, Mason DY (1985) Methods in laboratory investiagion. Use of free-dried paraffin-embedded sectrions for immunohistologic staining with monoclonal antibodies. Lab Invest 52:676–683 [PubMed] [Google Scholar]
  52. Taylor DR, Page, W, Hughes D, Varghese G (1987) Metastatic renal cell carcinoma mimicking pleural mesothelioma. Thorax 42:901–902 [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Tron V, Wright JL, Churg A (1987) Carcinoembryonic antigen and milk-fat globule staining of malignant mesothelioma and adenocarcinoma of the lung. Arch Pathol Lab Med 111:291–293 [PubMed] [Google Scholar]
  54. Upton MP, Hirohashi S, Tome Y, Miyazawa N, Suemasu K, Shimasotu Y (1986) Expression of vimentin in surgically resected adenocarcinomas and large cell carcinomas of lung. Am J Surg Pathol 10:560–567 [DOI] [PubMed] [Google Scholar]
  55. Wälchli P, Rajower I, Christen B, Mirza S, Rüttner JR (1987) de“Ferruginous bodies” im Lungenstaub als Indikatoren für Asbestschäden. Pathologe 8:346–350 [PubMed] [Google Scholar]
  56. Warnock ML, Stoloff A, Thor A (1988) Differentiation of adenocarcinoma of the lung from mesothelioma. Periodic-acid-Schiff, monoclonal antibodies B72.3, and LeuM1. Am J Pathol 133:30–38 [PMC free article] [PubMed] [Google Scholar]
  57. Whitaker D, Shilkin KB (1984) Diagnosis of pleural esothelioma in life — a practical approach. J Pathol 143:147–175 [DOI] [PubMed] [Google Scholar]
  58. Wick MR, Loy Th, Mills St, Legier JF, Manivel JC (1990) Malignant epitheloid pleural mesothelioma versus peripheral adenocarcinoma: histochemical, ultrastructural, and immunohistological study of 103 cases. Hum Pathol 21:759–766 [DOI] [PubMed] [Google Scholar]
  59. Wirth PR, Legier J, Wright GL (1991) Immunohistochemical evaluation of seven monoclonal antibodies for differentiation of pleural mesothelioma from lung carcinoma. Cancer 67:655–662 [DOI] [PubMed] [Google Scholar]
  60. Willis RA (1967) Pathology of tumours. Butterworth, London, p 181 [Google Scholar]

Articles from Journal of Cancer Research and Clinical Oncology are provided here courtesy of Springer

RESOURCES